The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Eleven Biotherapeutics, Inc. COM 286221106 610 1,907,008 SH   SOLE 1 1,907,008 0 0
Renewable Energy Group, Inc. COM NEW 75972A301 317 33,570 SH   SOLE 1 33,570 0 0
Agios Pharmaceuticals, Inc. COM 00847X104 78,373 1,930,369 SH   SOLE 1 1,930,369 0 0
Seres Therapeutics Inc. COM 81750R102 15,917 599,297 SH   SOLE 1 599,297 0 0